Literature DB >> 19629068

A woman with polycystic ovary syndrome treated for infertility by in vitro fertilization.

Thomas Tang1, Adam H Balen.   

Abstract

BACKGROUND: A 25-year-old South Asian woman presented at an infertility unit with a 2-year history of anovulatory infertility. She had experienced irregular and infrequent periods for over a decade. INVESTIGATIONS: Endocrine profile (follicle-stimulating hormone, luteinizing hormone, thyroid-function test, prolactin, testosterone), oral glucose tolerance test and pelvic ultrasonography were performed. DIAGNOSIS: Polycystic ovary syndrome, in accordance with the recent Rotterdam consensus (2004) criteria. MANAGEMENT: The patient failed to conceive by conventional ovulation-induction therapies with clomifene and gonadotropins. She subsequently underwent an in vitro fertilization cycle, to which she over-responded and developed a severe form of ovarian hyperstimulation syndrome. The diagnosis of ovarian hyperstimulation syndrome was based on clinical and ultrasonographic features. She was hospitalized and needed extensive supportive care, including insertion of chest and abdominal drains.

Entities:  

Mesh:

Year:  2009        PMID: 19629068     DOI: 10.1038/nrendo.2009.125

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  15 in total

1.  Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries.

Authors:  Rina Agrawal; Howard Jacobs; Nadia Payne; Gerard Conway
Journal:  Fertil Steril       Date:  2002-12       Impact factor: 7.329

2.  The use of metformin for women with PCOS undergoing IVF treatment.

Authors:  Thomas Tang; Julie Glanville; Nic Orsi; Julian H Barth; Adam H Balen
Journal:  Hum Reprod       Date:  2006-02-24       Impact factor: 6.918

3.  HCG in the regulation of placental angiogenesis. Results of an in vitro study.

Authors:  F Herr; N Baal; K Reisinger; A Lorenz; T McKinnon; K T Preissner; M Zygmunt
Journal:  Placenta       Date:  2007-03-26       Impact factor: 3.481

Review 4.  A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome.

Authors:  Michael F Costello; Michael Chapman; Una Conway
Journal:  Hum Reprod       Date:  2006-01-31       Impact factor: 6.918

Review 5.  Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.

Authors:  J M Lord; I H K Flight; R J Norman
Journal:  Cochrane Database Syst Rev       Date:  2003

6.  Insulin and insulin-like growth factor stimulation of vascular endothelial growth factor production by luteinized granulosa cells: comparison between polycystic ovarian syndrome (PCOS) and non-PCOS women.

Authors:  Meghan B Stanek; Sherri M Borman; Theodore A Molskness; Janine M Larson; Richard L Stouffer; Phillip E Patton
Journal:  J Clin Endocrinol Metab       Date:  2007-05-08       Impact factor: 5.958

7.  In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome.

Authors:  R Homburg; D Berkowitz; T Levy; D Feldberg; J Ashkenazi; Z Ben-Rafael
Journal:  Fertil Steril       Date:  1993-11       Impact factor: 7.329

Review 8.  Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome.

Authors:  Raj Mathur; Chandra Kailasam; Julian Jenkins
Journal:  Hum Fertil (Camb)       Date:  2007-06       Impact factor: 2.767

9.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

Authors: 
Journal:  Fertil Steril       Date:  2004-01       Impact factor: 7.329

10.  Consensus on infertility treatment related to polycystic ovary syndrome.

Authors: 
Journal:  Hum Reprod       Date:  2008-03       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.